Choose Municipal Ward
    CLICK HERE FOR DETAILED RESULTS
    News18»Business
    1-MIN READ

    BioNTech To Price Vaccine Below Market Rates, Differentiate Between Regions

    BioNTech To Price Vaccine Below Market Rates, Differentiate Between Regions

    BioNTech, first in the race to produce evidence of a working COVID19 vaccine, is planning to price the twoshot regimen below "typical market rates" and would differentiate pricing between countries or regions.

    FRANKFURT: BioNTech, first in the race to produce evidence of a working COVID-19 vaccine, is planning to price the two-shot regimen below “typical market rates” and would differentiate pricing between countries or regions.

    Speaking at a Financial Times online event, the German biotech firm’s strategy head Ryan Richardson said the price tag of the vaccine, which is co-developed with Pfizer and which has yet to win regulatory approval, would reflect the financial risks that its private-sector investors have incurred.

    “We’ve tried to pursue a balanced approach that recognises that innovation requires capital and investment so we plan to price our vaccine well below typical market rates reflecting the situation that we’re in and with the goal to insure broad-based access around the world,” Richardson said at the FT event.

    “I expect there to be differential pricing in certain regions of the world,” he added, declining to elaborate on the different price tags.

    Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

    Greater Hyderabad Municipal Corporation Elections 2020 Live Results - Ward-Wise Results | Detailed Results Tally | GHMC Results Live Updates
    Next Story
    Loading...